Danaher Co. (NYSE:DHR) Stake Boosted by Lmcg Investments LLC

Lmcg Investments LLC raised its position in shares of Danaher Co. (NYSE:DHR) by 1.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 95,097 shares of the conglomerate’s stock after purchasing an additional 955 shares during the quarter. Danaher accounts for about 1.6% of Lmcg Investments LLC’s investment portfolio, making the stock its 10th largest position. Lmcg Investments LLC’s holdings in Danaher were worth $26,439,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Ashton Thomas Private Wealth LLC increased its position in Danaher by 44.5% in the first quarter. Ashton Thomas Private Wealth LLC now owns 4,970 shares of the conglomerate’s stock worth $1,241,000 after purchasing an additional 1,530 shares during the last quarter. Norden Group LLC bought a new stake in Danaher in the first quarter worth $276,000. J.W. Cole Advisors Inc. increased its position in Danaher by 41.4% in the first quarter. J.W. Cole Advisors Inc. now owns 2,943 shares of the conglomerate’s stock worth $735,000 after purchasing an additional 861 shares during the last quarter. Private Advisor Group LLC increased its position in Danaher by 5.2% during the first quarter. Private Advisor Group LLC now owns 42,467 shares of the conglomerate’s stock valued at $10,605,000 after acquiring an additional 2,085 shares during the last quarter. Finally, Diversify Advisory Services LLC bought a new position in shares of Danaher in the first quarter worth about $401,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on DHR. Stephens restated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Leerink Partners increased their price target on Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Bank of America boosted their price objective on Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. KeyCorp increased their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Finally, Robert W. Baird dropped their price objective on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $287.16.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Price Performance

DHR stock traded up $2.10 during midday trading on Friday, reaching $247.76. The company had a trading volume of 2,638,494 shares, compared to its average volume of 2,752,238. Danaher Co. has a 1 year low of $190.95 and a 1 year high of $281.70. The company has a market capitalization of $178.95 billion, a P/E ratio of 47.29, a P/E/G ratio of 4.45 and a beta of 0.83. The firm has a 50-day moving average price of $266.95 and a 200-day moving average price of $260.37. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same period in the prior year, the business earned $2.02 EPS. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. On average, research analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.